Mallinckrodt
Baxter reveals plans to split pharma, medical products businesses
Covidien puts a bow on pharma spinout, Wall Street backs off
Meet the ‘New Covidien’
William Blair boosts NxStage stake by 20% | Wall Street Beat
William Blair & Co. added 20% to its holdings in NxStage Medical (NSDQ:NXTM) last year, according to regulatory filings.
The Chicago-based investment bank owned more than 3.8 million NXTM shares as of Dec. 31, 2012, up 19.5% from the 3.2 million shares it owned at the close of 2011.